Growth Hormone Shortage UK

Genotropin® (somatropin) 5.3 mg and 12 mg powder and solvent for solution for injection

• The reusable Pen device for Genotropin® (somatropin) 5.3 mg and 12 mg powder and solvent for solution for injection will be out of stock from the end of January 2026 until at least early 2027.
• Each reusable Pen has a battery life of approximately two years.
• Patients whose battery life expires during the out-of-stock period will need to be switched to an alternative device.
• Homecare patients currently using this pen device will be reviewed by their homecare provider to determine whether a switch is required during the shortage, and will continue to receive supplies from their homecare provider as appropriate.
• New patients should not be initiated on the Genotropin® Pen device, and new homecare referrals will not be accepted until the supply issue has resolved.
• Only the reuseable pen device is affected.

From the official notice: DHSC MSN/2025/072, issued 23 December 2025.